Wilsey Asset Management Inc Biogen Inc. Transaction History

Wilsey Asset Management Inc

  • $491 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021
SELL
$282.99 - $369.05 $6.43 Million - $8.38 Million
-22,708 Closed
0 $0
Q2 2021

Jul 26, 2021
SELL
$259.0 - $414.71 $62,937 - $100,774
-243 Reduced 1.06%
22,708 $7.86 Million
Q1 2021

Apr 28, 2021
BUY
$242.95 - $284.63 $26,481 - $31,024
109 Added 0.48%
22,951 $6.42 Million
Q4 2020

Feb 19, 2021
BUY
$236.26 - $355.63 $5.4 Million - $8.12 Million
22,842 New
22,842 $5.59 Million

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Wilsey Asset Management Inc Portfolio

Follow Wilsey Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilsey Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilsey Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email